Opinion

Video

Closing Thoughts From The Panel On Pneumococcal Vaccination

Author(s):

Christina M. Madison, PharmD, FCCP, AAHIVP,Mary Barna Bridgeman, PharmD, BCPS, BCGP, FASCP

The panel of pneumococcal vaccination experts offer their concluding insights and perspectives on the current landscape of pneumococcal vaccines.

Related Videos
5 experts in this video
5 experts in this video
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
5 experts in this video
5 experts in this video
5 experts in this video
5 experts in this video
Related Content
3D Medical Illustration of Pneumococcal Pneumonia Showing Streptococcus Pneumoniae Bacteria in Human Lungs
April 22nd 2025

Surveillance, Targeted Interventions Critical to Combat Variable Nature of Invasive Pneumococcal Disease

Luke Halpern, Assistant Editor
Insights from a Pharmacy Times Peer Exchange: ADC Drug Design and HER2 Ultra-Low Breast Cancer Indiciations
April 29th 2025

Insights from a Pharmacy Times Peer Exchange: ADC Drug Design and HER2 Ultra-Low Breast Cancer Indiciations

Alexandra Gerlach, Associate Editor
Streptococcus pneumoniae or pneumococcus bacterias
April 15th 2025

Little Association Found Between Pneumococcal Vaccination and Severe COVID-19 Outcomes in Older Adults

Luke Halpern, Assistant Editor
Antibody Drug Conjugates and Breast Cancer: Insights from a Pharmacy Times Peer Exchange
April 14th 2025

Antibody Drug Conjugates and Breast Cancer: Insights from a Pharmacy Times Peer Exchange

Alexandra Gerlach, Associate Editor
Pneumococcal vaccine bottles and syringes for preventing pneumonia.
April 2nd 2025

Single Dose of PCV20 for Toddlers Following Previous PCV13 Doses Protects Against Additional Pneumococcal Serotypes

Luke Halpern, Assistant Editor
Socioeconomic Inequities Have a Significant Impact on Treatment of Antimicrobial Resistant Infections
January 28th 2025

Socioeconomic Inequities Have a Significant Impact on Treatment of Antimicrobial Resistant Infections

Camille Cabas, PharmD